Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974
Report date:
1974

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
GLP compliance:
no
Type of assay:
chromosome aberration assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Silicon dioxide
EC Number:
231-545-4
EC Name:
Silicon dioxide
Cas Number:
7631-86-9
Molecular formula:
O2Si
IUPAC Name:
dioxosilane
Test material form:
solid: nanoform, no surface treatment
Details on test material:
Silica gel; CAS-No. 7631-86-9; EINECS-No. 231-545-4; BET: 340 - 390 m2/g
Specific details on test material used for the study:
synthetic amorphous silicon dioxide Syloid 244

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- vehicle: 0.85 % saline
- Volume of the vehicle: no data
- Justification for choice of solvent/vehicle: no data
- Concentration of test material in vehicle: no data


MAXIMUM DOSE VOLUME APPLIED: no data
Details on exposure:
3 time points: sampling at 6, 24, and 48 h in the single-dose study
1 time point: sampling at 6 h after the last dose in the repeated-dose study

Colcemide (4 mg/kg bw i.p) was given 2 h prior to kill.
Duration of treatment / exposure:
single administration (acute) and repeated administration (5 times, subacute)
Frequency of treatment:
1x, and 5x(1x/d)
Doses / concentrationsopen allclose all
Dose / conc.:
1.4 mg/kg bw/day (actual dose received)
Dose / conc.:
14 mg/kg bw/day (actual dose received)
Dose / conc.:
140 mg/kg bw/day (actual dose received)
Dose / conc.:
500 mg/kg bw/day (actual dose received)
Dose / conc.:
5 000 mg/kg bw/day (nominal)
No. of animals per sex per dose:
5; but 3 as vehicle control
Control animals:
yes, concurrent vehicle
Positive control(s):
triethylenemelamine
- Route of administration: i.p.
- Doses / concentrations: 0.3 mg/kg bw

Examinations

Tissues and cell types examined:
bone-marrow cells

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Toxicity:
not specified
Vehicle controls validity:
valid
Positive controls validity:
valid

Applicant's summary and conclusion

Conclusions:
synthetic amorphous silicon dioxide Syloid 244 was negativein in in vivo chromosome aberration test.
Executive summary:

An in vivo chromosome aberration test similar to OECD 475 was conducted with synthetic amorphous silicon dioxide Syloid 244